| Name | SPEM family member 3 |
| Description | Predicted to be involved in flagellated sperm motility and sperm individualization. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe NF‑κB transcription factor is subject to tight regulation by a family of inhibitory proteins (IκBs), where distinct isoforms play complementary roles in controlling the amplitude and timing of NF‑κB responses. Computational and genetic studies show that IκBα confers robust, rapid negative feedback essential for signal termination, whereas IκBβ and IκBε tailor the kinetics of the response and dampen oscillatory behavior (‐a finding supported by studies demonstrating differential degradation and synthesis dynamics ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]). Moreover, joint disruption of IκBα and IκBε in vivo provokes severe consequences for lymphocyte survival and differentiation, as evidenced by the loss of B and T cells and impaired natural killer cell maturation ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIκBε, in particular, has emerged as a non‐redundant modulator of NF‑κB activity. Its selective binding to NF‑κB subunits like c‑Rel underpins its role in fine‐tuning gene expression, thus affecting both innate immune responses and lymphoid cell function. Detailed mechanistic studies have revealed that the regulatory capacity of nuclear IκB proteins involves conserved residues that mediate direct interactions with NF‑κB dimers and their target promoters, thereby influencing the transcription of key effector molecules ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "7"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to these classical feedback mechanisms, recent evidence has highlighted a pivotal role for the proteasome activator complex subunit 3—referred to here as SPEM3—in modulating NF‑κB signaling. SPEM3 facilitates the specific degradation of IκBε, thereby enhancing NF‑κB activation during inflammatory responses. In testicular Leydig cells, SPEM3 deficiency protects against inflammatory-induced reductions in testosterone secretion by curtailing the phosphorylation of NF‑κB and subsequent pro‐inflammatory gene expression. Parallel findings in chronic lymphocytic leukemia underscore that mutations impairing IκBε regulation contribute to aberrantly high NF‑κB activity and an altered tumor microenvironment that favors immune escape and reduced drug sensitivity ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "].\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alexander Hoffmann, Andre Levchenko, Martin L Scott, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1071914"}], "href": "https://doi.org/10.1126/science.1071914"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12424381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12424381"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ellen L O'Dea, Derren Barken, Raechel Q Peralta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Syst Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/msb4100148"}], "href": "https://doi.org/10.1038/msb4100148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17486138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17486138"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Bertrand Goudeau, François Huetz, Sandrine Samson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2535880100"}], "href": "https://doi.org/10.1073/pnas.2535880100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14665694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14665694"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sandrine I Samson, Sylvie Mémet, Christian A J Vosshenrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2003-08-2975"}], "href": "https://doi.org/10.1182/blood-2003-08-2975"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14764534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14764534"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Joanna M Clark, Karolina Aleksiyadis, Alex Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0024504"}], "href": "https://doi.org/10.1371/journal.pone.0024504"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21915344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21915344"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Akira Kohda, Soh Yamazaki, Hideki Sumimoto "}, {"type": "b", "children": [{"type": "t", "text": "The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.719302"}], "href": "https://doi.org/10.1074/jbc.M116.719302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27489104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27489104"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Stefan Doerre, Kristin Perkins Mesires, Kylle M Daley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.174.2.983"}], "href": "https://doi.org/10.4049/jimmunol.174.2.983"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15634922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15634922"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tiancheng Xie, Hui Chen, Shihui Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteasome activator REGγ promotes inflammation in Leydig cells via IkBε signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2019.4115"}], "href": "https://doi.org/10.3892/ijmm.2019.4115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30816488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30816488"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Alice Bonato, Supriya Chakraborty, Riccardo Bomben, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41375-024-02224-8"}], "href": "https://doi.org/10.1038/s41375-024-02224-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38486128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38486128"}]}]}]}
|
| NCBI Gene ID | 107983988 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SPEM3 has 291 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 10 datasets.
Click the + buttons to view associations for SPEM3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SPEM3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SPEM3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SPEM3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SPEM3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SPEM3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SPEM3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SPEM3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SPEM3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SPEM3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SPEM3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |